Bulletin
Investor Alert

Novartis AG ADR

NYS: NVS

GO
/marketstate/country/us

After Hours

NVS
/zigman2/quotes/203243705/composite

$

84.90

Change

+0.45 +0.53%

Volume

Volume 48,248

May 27, 2020, 7:38 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203243705/composite

Previous close

$ 85.05

$ 84.45

Change

-0.60 -0.71%

Day low

Day high

$83.25

$84.51

Open
Open: 84.24

52 week low

52 week high

$69.18

$99.84

Open

Market cap

$192.64B

Average volume

2.31M

P/E ratio

16.70

Rev. per Employee

$415,614

EPS

5.06

Dividend

3.09

Div yield

2.38%

Ex dividend date

3/3/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvs

MarketWatch News on NVS

  1. 13 Stock Ideas From Top Value Managers

    8:00 a.m. May 14, 2020

    - Reshma Kapadia

  2. Astrazeneca’s First Quarter Shows Stock Can Weather the Storm

    11:22 a.m. April 29, 2020

    - Lina Saigol

  3. Regeneron Stock Has Hit Its Peak, Says Citi

    11:36 a.m. April 28, 2020

    - Bill Alpert

  4. Novartis sales and net income rises

    1:47 a.m. April 28, 2020

  5. Novartis to run COVID-19 trial of antimalaria drug touted by Trump

    9:01 a.m. April 20, 2020

    - Steve Goldstein

  6. Incyte, Novartis launch drug study to treat coronavirus complication

    4:49 p.m. April 17, 2020

    - Wallace Witkowski

  7. Demand Spikes for a Drug Studied as Covid-19 Cure

    9:57 a.m. March 24, 2020

    - Josh Nathan-Kazis

  8. 18 Stock Picks for Turbulent Times

    8:24 p.m. March 13, 2020

    - Lauren R. Rublin

  9. Ionis Pharmaceuticals Has a Great Pipeline of New Drugs, Analyst Says

    8:18 a.m. March 5, 2020

    - Josh Nathan-Kazis

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvs

Other News on NVS

  1. IPO Update: Pliant Therapeutics Readies U.S. IPO

    1:39 p.m. May 27, 2020

    - Seeking Alpha

  2. Tracking David Einhorn's Portfolio - Q1 2020 Update

    2:35 p.m. May 23, 2020

    - Seeking Alpha

  3. Legend Biotech Seeks U.S. Capital For Pipeline Advance

    4:38 p.m. May 19, 2020

    - Seeking Alpha

  4. Calliditas Therapeutics Seeks U.S. Capital Via IPO

    4:14 p.m. May 19, 2020

    - Seeking Alpha

  5. Priced To Perfection: AstraZeneca Is A Sell

    4:11 p.m. May 19, 2020

    - Seeking Alpha

  6. Novartis SMA gene therapy OK'd in Europe

    6:56 a.m. May 19, 2020

    - Seeking Alpha

  7. Our Chief Picks In Pharma

    12:01 a.m. May 19, 2020

    - Seeking Alpha

  8. Retirement: 10 Recession-Proof DGI Stocks (Almost)

    9:31 a.m. May 16, 2020

    - Seeking Alpha

  9. Tracking Kahn Brothers Portfolio - Q1 2020 Update

    6:02 a.m. May 14, 2020

    - Seeking Alpha

  10. FDA accepts Arbor Pharma application for ADHD med AR19

    11:05 a.m. May 13, 2020

    - Seeking Alpha

  11. ADC Therapeutics Cuts Price In Second IPO Attempt

    12:29 p.m. May 11, 2020

    - Seeking Alpha

  12. Puma's (PBYI) Earnings and Revenues Beat Estimates in Q1

    12:01 p.m. May 11, 2020

    - Zacks.com

  13. Loading more headlines...
/news/pressrelease/company/us/nvs

Press Releases on NVS

  1. Drug Discovery Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2027

    12:21 a.m. Today

    - Market Insight Reports

  2. High Potency APIs-HPAPI Market Status and Future Forecasts to 2026

    11:10 a.m. May 27, 2020

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.